Top Markets
Coin of the day
Dong Sung Bio Pharm.Co.,Ltd. Dong Sung Bio Pharm.Co.,Ltd.

Dong Sung Bio Pharm.Co.,Ltd.

002210
Rang in aandelen #28308
Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations... Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations spanning pharmaceuticals, cosmetics, hair dye manufacturing, and photodynamic therapy. Its extensive product range includes a broad selection of over-the-counter (OTC) medications designed to treat a variety of conditions. These encompass liver ailments, menopausal symptoms, skin disorders, obesity, digestive and gum health issues, and hair loss. The company's OTC offerings also feature remedies for fever, pain, inflammation, respiratory illnesses, scar reduction, and sleep disturbances, along with antiviral, anti-diarrhea, anti-nausea, blood circulation enhancing, antifungal, and antihistamine drugs. Supplementary OTC products include keratin softeners, eye nutrition supplements, and essential vitamins. Furthermore, Dong Sung Bio Pharm produces ethical (prescription-only, or ETC) drugs. These target specific medical areas such as endocrine, gastrointestinal, circulatory, neuropsychological, and oncological conditions. Its ETC portfolio also contains analgesic and anti-inflammatory agents, dermato-urinary treatments, antiviral, antibiotic, antifungal, and antihistamine medications, as well as respiratory drugs, steroids, and ophthalmic drops. Beyond its pharmaceutical lines, the company offers a range of consumer health and personal care items. These include hair coloring products, functional health foods, medical devices, various daily necessities, muscle taping supplies, disinfectants, toothpastes, shampoos for anti-hair loss and hair growth, and sanitary pads. Dong Sung Bio Pharm.Co.,Ltd. was founded in 1957 and maintains its headquarters in Seoul, South Korea.
Aandeelprijs
$1.11
Marktkapitalisatie
$27.17M
Verandering (1 dag)
0.19%
Verandering (1 jaar)
58.22%
Land
KR
Handel Dong Sung Bio Pharm.Co.,Ltd. (002210)

Categorie

EPS voor Dong Sung Bio Pharm.Co.,Ltd. (002210)
EPS per March 2026 TTM: $-0.70
Volgens de laatste financiële rapporten en de aandelenkoers van Dong Sung Bio Pharm.Co.,Ltd. is de huidige EPS van het bedrijf (TTM) $-0.70. Eind 2023 had het bedrijf een EPS van $-0.07, gelijk aan de EPS van 2022 die $-0.07 bedroeg.
EPS-geschiedenis van Dong Sung Bio Pharm.Co.,Ltd. van 2007 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
2026 (TTM) $-0.70 217.00%
2024 $-0.22 208.27%
2023 $-0.07 -4.10%
2022 $-0.07 -52.90%
2021 $-0.16 -71.91%
2020 $-0.55 75.51%
2019 $-0.31 19.65%
2018 $-0.26 2,698.94%
2017 $-0.01 -86.40%
2016 $-0.07 -452.55%
2015 $0.02 -103.64%
2014 $-0.54 415.12%
2013 $-0.10 -161.47%
2012 $0.17 105.31%
2011 $0.08 -121.05%
2010 $-0.39 -1,573.03%
2009 $0.03 -82.85%
2008 $0.16 -4.48%
2007 $0.16 0.00%
EPS van vergelijkbare bedrijven of concurrenten